Executive officer

Eric S. Whitaker

Strategic Counsel (former Chief Legal Officer)·10x Genomics, Inc.

About

Eric S. Whitaker served as General Counsel of 10x Genomics from July 2017 and later as its Chief Legal Officer. On November 12, 2025 he announced his retirement as Chief Legal Officer effective January 1, 2026, after which he remained an employee as Strategic Counsel.

Before joining 10x Genomics he was Chief Legal Officer of Nutanix (September 2014-May 2017), Chief Legal Officer of SanDisk (January 2013-September 2014) and General Counsel of Tesla (October 2010-November 2012), and earlier served as General Counsel for a number of technology companies and worked as an attorney at Latham & Watkins LLP.

He holds a J.D. from Stanford Law School and a B.A. in Politics from Princeton University.

Since 2017
Tenure 9 yrs

Also at 10x Genomics, Inc.

SS Serge Saxonov Chief Executive Officer and Director BH Benjamin J. Hindson Chief Scientific Officer, President and Director JS John R. Stuelpnagel Chairman of the Board of Directors AM Alan Mateo Director KP Kimberly J. Popovits Director ST Sarah Teichmann Director

Roles

Organization Role Dates Details
10x Genomics, Inc. Strategic Counsel (former Chief Legal Officer) 2017–present Current role
10x Genomics General Counsel / Chief Legal Officer July 2017 - January 2026 Transitioned to Strategic Counsel effective January 1, 2026.
Nutanix Chief Legal Officer September 2014 - May 2017
SanDisk Chief Legal Officer January 2013 - September 2014
Tesla General Counsel October 2010 - November 2012
Latham & Watkins LLP Attorney

Related

Company 10x Genomics, Inc. Company hub Person Serge Saxonov Chief Executive Officer and Director Person Benjamin J. Hindson Chief Scientific Officer, President and Director Person John R. Stuelpnagel Chairman of the Board of Directors Person Alan Mateo Director Person Kimberly J. Popovits Director Person Sarah Teichmann Director Person Sri Kosaraju Director Person Shehnaaz Suliman Director Person Adam S. Taich Chief Financial Officer Person Randy Wu General Counsel and Secretary
Source: 10x Genomics, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo